ALGN Stock - Align Technology, Inc.
Unlock GoAI Insights for ALGN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B |
| Gross Profit | $2.80B | $2.71B | $2.63B | $2.94B | $1.76B |
| Gross Margin | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% |
| Operating Income | $607.63M | $643.34M | $642.60M | $976.40M | $387.17M |
| Net Income | $421.36M | $445.05M | $361.57M | $772.02M | $1.78B |
| Net Margin | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% |
| EPS | $5.63 | $5.82 | $4.62 | $9.78 | $22.55 |
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 9th 2025 | Barclays | Initiation | Equal Weight | $170 |
| October 10th 2025 | Jefferies | Downgrade | Hold | $140 |
| July 31st 2025 | Morgan Stanley | Downgrade | Equal Weight | $154 |
| April 25th 2025 | HSBC Securities | Downgrade | Hold | $170 |
| February 14th 2025 | Wells Fargo | Initiation | Overweight | $255 |
| January 6th 2025 | Leerink Partners | Upgrade | Outperform | $280← $235 |
| December 4th 2024 | Mizuho | Initiation | Outperform | $295 |
| October 10th 2024 | Needham | Initiation | Hold | - |
| February 26th 2024 | Leerink Partners | Initiation | Market Perform | $310 |
| December 11th 2023 | Goldman | Downgrade | Sell | $197 |
| October 27th 2023 | UBS | Downgrade | Neutral | $200 |
| February 2nd 2023 | Goldman | Upgrade | Neutral | $307← $165 |
| July 28th 2022 | Goldman | Downgrade | Sell | $250← $380 |
Earnings History & Surprises
ALGNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $2.99 | — | — | — |
Q4 2025 | Oct 29, 2025 | $2.37 | $2.61 | +10.1% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $2.57 | $2.49 | -3.1% | ✗ MISS |
Q2 2025 | Apr 30, 2025 | $1.99 | $2.13 | +7.0% | ✓ BEAT |
Q1 2025 | Feb 5, 2025 | $2.43 | $2.44 | +0.4% | ✓ BEAT |
Q4 2024 | Oct 23, 2024 | $2.31 | $2.35 | +1.7% | ✓ BEAT |
Q3 2024 | Jul 24, 2024 | $2.34 | $2.41 | +3.0% | ✓ BEAT |
Q2 2024 | Apr 24, 2024 | $1.97 | $2.14 | +8.6% | ✓ BEAT |
Q1 2024 | Jan 31, 2024 | $2.18 | $2.42 | +11.0% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $2.26 | $2.14 | -5.3% | ✗ MISS |
Q3 2023 | Jul 26, 2023 | $2.02 | $2.22 | +9.9% | ✓ BEAT |
Q2 2023 | Apr 26, 2023 | $1.69 | $1.82 | +7.7% | ✓ BEAT |
Q1 2023 | Feb 1, 2023 | $1.52 | $1.73 | +13.8% | ✓ BEAT |
Q4 2022 | Oct 26, 2022 | $2.21 | $1.36 | -38.5% | ✗ MISS |
Q3 2022 | Jul 27, 2022 | $2.12 | $2.00 | -5.7% | ✗ MISS |
Q2 2022 | Apr 27, 2022 | $2.22 | $2.13 | -4.1% | ✗ MISS |
Q1 2022 | Feb 2, 2022 | $2.71 | $2.83 | +4.4% | ✓ BEAT |
Q4 2021 | Oct 27, 2021 | $2.60 | $2.87 | +10.4% | ✓ BEAT |
Q3 2021 | Jul 28, 2021 | $2.53 | $3.04 | +20.2% | ✓ BEAT |
Latest News
Barclays Initiates Coverage On Align Technology with Equal-Weight Rating, Announces Price Target of $170
➖ NeutralReported Earlier, Align Technology Launches Invisalign System With Mandibular Advancement Featuring Occlusal Blocks For Class II Malocclusion In Growing Patients
📈 PositiveAlign Technology shares are trading higher after the company announced commercial availability in the Philippines of the Invisalign System with mandibular advancement featuring occlusal blocks.
📈 PositiveReported Earlier, Align Technology Announced Commercial Availability In The Philippines Of The Invisalign System With Mandibular Advancement Featuring Occlusal Blocks Designed Specifically To Address Class II Skeletal And Dental Correction
📈 PositiveAlign Technology Launches Research Award Program To Support Clinical, Scientific Dental Research Globally
📈 PositiveMorgan Stanley Maintains Equal-Weight on Align Technology, Raises Price Target to $154
➖ NeutralEvercore ISI Group Maintains Outperform on Align Technology, Raises Price Target to $170
📈 PositiveWells Fargo Maintains Overweight on Align Technology, Lowers Price Target to $181
➖ NeutralPiper Sandler Reiterates Overweight on Align Technology, Raises Price Target to $200
📈 PositiveAlign Technology shares are trading higher after the company reported better-than-expected Q3 financial results.
📈 PositiveAlign Technology shares are trading higher after the company reported better-than-expected Q3 financial results.
📈 PositiveAlign Technology Sees Q4 Sales $1.025B-$1.045B vs $1.032B Est
➖ NeutralAlign Tech Q3 Adj. EPS $2.61 Beats $2.40 Estimate, Sales $995.692M Beat $976.332M Estimate
📈 PositiveMorgan Stanley Maintains Equal-Weight on Align Technology, Lowers Price Target to $142
➖ NeutralUBS Maintains Neutral on Align Technology, Lowers Price Target to $155
➖ NeutralMizuho Maintains Outperform on Align Technology, Lowers Price Target to $170
➖ NeutralJefferies Downgrades Align Technology to Hold, Lowers Price Target to $140
📉 NegativeEvercore ISI Group Maintains Outperform on Align Technology, Lowers Price Target to $160
➖ NeutralReported Earlier, Align Technology Advances Digital Orthodontics With Invisalign By Hosting Global Faculty Meeting Of 100+ Doctor Educators
📈 PositiveReported Earlier, Align Technology Launches Align Women's Smile Collective At 2025 Invisalign GP Summit Spotlighting Women Shaping The Future Of Dentistry
📈 PositiveFrequently Asked Questions about ALGN
What is ALGN's current stock price?
What is the analyst price target for ALGN?
What sector is Align Technology, Inc. in?
What is ALGN's market cap?
Does ALGN pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ALGN for comparison